Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease.
PMID:35241825
Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry.
PMID:35052416
Sequencing-based genome-wide association studies reporting standards.
PMID:34870259
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
PMID:34782789
An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.
PMID:34711957
The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits.
PMID:34595549
Epicardial Adipose Tissue: The Genetics Behind an Emerging Cardiovascular Risk Marker.
PMID:34276231
Health equality, race and pharmacogenomics.
PMID:34251046
Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma 2 may be associated with adverse neurodevelopment in European preterm babies.
PMID:34152086
Automated AI labeling of optic nerve head enables insights into cross-ancestry glaucoma risk and genetic discovery in >280,000 images from UKB and CLSA.
PMID:34077762
The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy.
PMID:33983834
The Need for a Human Pangenome Reference Sequence.
PMID:33929893
How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
PMID:33889936
Human OMICs and Computational Biology Research in Africa: Current Challenges and Prospects.
PMID:33794662
Advancing drug discovery using the power of the human genome.
PMID:33748968
Improving reporting standards for polygenic scores in risk prediction studies.
PMID:33692554
Ethical Principles, Constraints and Opportunities in Clinical Proteomics.
PMID:33453411
Population-Matched Transcriptome Prediction Increases TWAS Discovery and Replication Rate.
PMID:33313492
The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine.
PMID:33302594
Highly diversified core promoters in the human genome and their effects on gene expression and disease predisposition.
PMID:33256598
Diversity matters: opportunities in the study of the genetics of psychotic disorders in low- and middle-income countries in Latin America.
PMID:33237255
PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis.
PMID:32728045
Genome-wide association study of cognitive function in diverse Hispanics/Latinos: results from the Hispanic Community Health Study/Study of Latinos.
PMID:32699239
Ancestry effects on type 2 diabetes genetic risk inference in Hispanic/Latino populations.
PMID:32580712
Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents.
PMID:32541000
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.
PMID:32514122
Polygenic risk scores: from research tools to clinical instruments.
PMID:32423490
Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.
PMID:32324503
Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway.
PMID:32313116
Personalised nutrition technologies: a new paradigm for dietetic practice and training in a digital transformation era.
PMID:32173947
Ancestry-specific associations identified in genome-wide combined-phenotype study of red blood cell traits emphasize benefits of diversity in genomics.
PMID:32171239
Evaluating the promise of inclusion of African ancestry populations in genomics.
PMID:32140257
Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus.
PMID:31921420
Structural variation in the sequencing era.
PMID:31729472
Diversity In Precision Medicine And Pharmacogenetics: Methodological And Conceptual Considerations For Broadening Participation.
PMID:31686892
Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer.
PMID:31683572
Risky behaviors and Parkinson disease: A mendelian randomization study.
PMID:31527283
The genetic architecture of Parkinson's disease.
PMID:31521533
Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity.
PMID:31392599
Rare and common variant discovery in complex disease: the IBD case study.
PMID:31363759
Clinical use of current polygenic risk scores may exacerbate health disparities.
PMID:30926966
Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations.
PMID:30787307
African American ancestry contribution to asthma and atopic dermatitis.
PMID:30772392
Predicting Polygenic Risk of Psychiatric Disorders.
PMID:30737014
Host and Microbiome Genome-Wide Association Studies: Current State and Challenges.
PMID:30723493
A scientometric review of genome-wide association studies.
PMID:30623105
Genetics of Obesity in Diverse Populations.
PMID:30456705
The clinical imperative for inclusivity: Race, ethnicity, and ancestry (REA) in genomics.
PMID:30311373
The critical needs and challenges for genetic architecture studies in Africa.
PMID:30240950
Enhancing diversity to reduce health information disparities and build an evidence base for genomic medicine.
PMID:30209973
Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative.
PMID:29779563